Position in XFOR
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$24
+$0 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in XFOR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HighMark Wealth Management LLC holds $19,716,375 across 37 Biotechnology names. XFOR ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CNTA |
Centessa Pharmaceuticals plc
|
236,785 | $9,405,100 | |
| 2 | ANAB |
Anaptysbio, Inc
|
94,050 | $5,216,008 | |
| 3 | EWTX |
Edgewise Therapeutics, Inc.
|
53,179 | $1,675,138 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
23,000 | $1,337,450 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
20,495 | $744,378 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
35,196 | $521,604 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
55,878 | $220,718 | |
| 8 | PLRX |
Pliant Therapeutics, Inc.
|
166,224 | $209,442 |
All Filings in XFOR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24 | 6 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $24 | 6 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $20 | 6 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $11 | 6 | Shares | Sole | 2025-07-21 | |
| No filing history on record for this holder in this stock. | ||||||